Contact Congress about S. 998: Medical Supply Chain Resiliency Act

The President could make trade deals that help medicines and medical devices move into the United States more easily. Congress would review each deal and could block it before it starts.

Modern Action explains what the legislation does, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Medical Supply Chain Resiliency Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Finance.

Latest action on S. 998: Read twice and referred to the Committee on Finance.

Who this affects: This bill mainly affects companies that make, import, or ship medicines, medical devices, and the materials used to produce them. It also affects hospitals, clinics, and patients because it could change how steady medical supplies are during a crisis. Federal trade and health agencies would have new work to review deals, monitor partners, and enforce the rules. Congress would have a formal role before any agreement takes effect.

Why this matters: The bill matters because the United States can run short on key medical supplies when demand spikes during a crisis. It tries to keep more supply lines open by using trade deals with trusted countries. That could help move needed goods faster and reduce dependence on a small number of suppliers. The real effect would depend on which countries join, what each agreement says, and whether partners follow the rules.

Key provisions in S. 998

• The bill covers medical goods. That means human drugs, medical devices, and the parts or materials used to make them, at every stage from design to delivery.
• The President could change import taxes and other limits on medical goods. This power applies only through a trusted trade partner agreement that supports U.S. national security and public health.
• The President must review a country before starting talks. That review includes open medical trade during health emergencies, past trade promises, rule of law, intellectual property protection, and fair regulation.
• Deals could make medical trade easier in several ways. They may lower tariffs and quotas, align safety rules, add suppliers, speed border checks, strengthen intellectual property rules, and exempt partners from some emergency trade limits.
• The President must update Congress during talks. A status report is due every 180 days.

How Modern Action helps you take action on S. 998

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about S. 998

What is S. 998?

The President could make trade deals that help medicines and medical devices move into the United States more easily. Congress would review each deal and could block it before it starts.

How do I support or oppose S. 998?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about S. 998?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

How does Modern Action help me act on S. 998?

Modern Action gives you bill-specific context, lets you choose support, opposition, or changes, and drafts a message from your position and reasons.